FK506 therapy of experimental autoimmune myocarditis after onset of the disease
- 1 December 1993
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 126 (6) , 1385-1392
- https://doi.org/10.1016/0002-8703(93)90538-k
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in ratsClinical Immunology and Immunopathology, 1992
- The effects of a new immunosuppressive agent, FK506, on the glomerular injury in rats with accelerated nephrotoxic serum glomerulonephritisClinical Immunology and Immunopathology, 1990
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990
- A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilinNature, 1989
- Recently diagnosed idiopathic dilated cardiomyopathy: Incidence of myocarditis and efficacy of prednisone therapyAmerican Heart Journal, 1989
- Active Myocarditis in the Spectrum of Acute Dilated CardiomyopathiesNew England Journal of Medicine, 1985
- Treatment of viral myocarditis with ribavirin in an animal preparation.Circulation, 1985
- Diagnosis and Classification of Myocarditis by Endomyocardial BiopsyNew England Journal of Medicine, 1983
- Immunosuppressive therapy in patients with congestive cardiomyopathy and myocardial uptake of gallium-67.Circulation, 1981
- Myocarditis of unknown etiology (Fiedler's?) treated with ACTH: Report of a case in a 7-year-old boy with improvementThe Journal of Pediatrics, 1953